Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation–Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation

Michael Mengel(University of Alberta), Alexandre Loupy(Inserm), Mark Haas(Cedars-Sinai Medical Center), Candice Roufosse(North West London Pathology), Maarten Naesens(KU Leuven), Enver Akalin(Albert Einstein College of Medicine), Marian C. Clahsen‐van Groningen(Erasmus MC), Jessy Dagobert(Inserm), Anthony J. Demetris(University of Pittsburgh Medical Center), Jean–Paul Duong Van Huyen(Inserm), Juliette Gueguen(Inserm), Fadi Issa(University of Oxford), Blaise Robin(Inserm), Ivy A. Rosales(Harvard University), Jan H. von der Thüsen(Erasmus MC), Alberto Sánchez‐Fueyo(King's College London), R. Neal Smith(Harvard University), Kathryn J. Wood(University of Oxford), Benjamin Adam(University of Alberta), Robert B. Colvin(Harvard University)
American Journal of Transplantation
May 19, 2020
Cited by 209Open Access
Full Text

Abstract

This meeting report from the XV Banff conference describes the creation of a multiorgan transplant gene panel by the Banff Molecular Diagnostics Working Group (MDWG). This Banff Human Organ Transplant (B-HOT) panel is the culmination of previous work by the MDWG to identify a broadly useful gene panel based on whole transcriptome technology. A data-driven process distilled a gene list from peer-reviewed comprehensive microarray studies that discovered and validated their use in kidney, liver, heart, and lung transplant biopsies. These were supplemented by genes that define relevant cellular pathways and cell types plus 12 reference genes used for normalization. The 770 gene B-HOT panel includes the most pertinent genes related to rejection, tolerance, viral infections, and innate and adaptive immune responses. This commercially available panel uses the NanoString platform, which can quantitate transcripts from formalin-fixed paraffin-embedded samples. The B-HOT panel will facilitate multicenter collaborative clinical research using archival samples and permit the development of an open source large database of standardized analyses, thereby expediting clinical validation studies. The MDWG believes that a pathogenesis and pathway based molecular approach will be valuable for investigators and promote therapeutic decision-making and clinical trials.


Related Papers

No related papers found

Powered by citation graph analysis